Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

5 structures for Q9NQT5

Entry ID Method Resolution Chain Position Source
2NN6 X-ray 335 A G 1-275 PDB
6D6Q EM 345 A G 1-275 PDB
6D6R EM 345 A G 1-275 PDB
6H25 EM 380 A G 1-275 PDB
AF-Q9NQT5-F1 Predicted AlphaFoldDB

288 variants for Q9NQT5

Variant ID(s) Position Change Description Diseaes Association Provenance
RCV001165974
CA5062882
rs549030188
RCV000658406
5 A>S Pontocerebellar hypoplasia type 1B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs758230758
RCV001204382
CA373476171
RCV002561156
13 A>P Pontocerebellar hypoplasia type 1B Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA5062870
RCV001165973
rs758230758
13 A>T Pontocerebellar hypoplasia type 1B [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000923637
rs147135294
RCV002542175
CA5062864
18 R>C Pontocerebellar hypoplasia type 1B Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000923636
CA5062863
rs145677716
RCV002541008
18 R>P Pontocerebellar hypoplasia type 1B Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
CA342800
rs387907196
RCV000024369
RCV001092265
RCV000853550
VAR_068505
31 G>A Fetal akinesia deformation sequence 1 Pontocerebellar hypoplasia type 1B PCH1B [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
ExAC
dbSNP
gnomAD
RCV000117004
rs587780333
38 E>missing Pontocerebellar hypoplasia type 1B [ClinVar] Yes ClinVar
dbSNP
RCV001168861
RCV000877718
rs114878910
CA5062847
51 R>G Pontocerebellar hypoplasia type 1B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000314149
RCV002509341
rs886041316
RCV000499694
52 P>missing Pontocerebellar hypoplasia type 1B Pontoneocerebellar hypoplasia [ClinVar] Yes ClinVar
dbSNP
RCV000418914
RCV002523792
CA5062844
rs148348866
RCV000874627
56 N>H Pontocerebellar hypoplasia type 1B Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs62640002
RCV000192646
RCV000865460
CA205604
RCV001545046
65 V>I Pontocerebellar hypoplasia type 1B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA345539
RCV000825519
RCV000117005
RCV001200535
VAR_074169
rs374550999
80 V>F Pontocerebellar hypoplasia type 1B Pontoneocerebellar hypoplasia [ClinVar] Yes ClinGen
ClinVar
UniProt
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000024368
rs672601331
99 V>missing Pontocerebellar hypoplasia type 1B [ClinVar] Yes ClinVar
dbSNP
RCV000699890
RCV000193472
rs138169215
CA206987
110 V>I Pontocerebellar hypoplasia type 1B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA5062774
rs145622193
RCV001043581
121 V>M Pontocerebellar hypoplasia type 1B Variant assessed as Somatic; 0.0 impact. [ClinVar, NCI-TCGA] Yes ClinGen
ClinVar
ESP
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
RCV000024366
RCV000190687
RCV001836713
RCV000761614
rs141138948
VAR_068506
RCV000224817
RCV003156064
CA204654
132 D>A Pontocerebellar hypoplasia type 1B Inborn genetic diseases PCH1B [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001064055
rs1828647523
135 G>R Pontocerebellar hypoplasia type 1B [ClinVar] Yes ClinVar
dbSNP
RCV000024367
VAR_068507
CA260045
rs387907195
139 A>P Pontocerebellar hypoplasia type 1B PCH1B [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
TOPMed
dbSNP
gnomAD
RCV001298964
rs145464176
CA5062759
RCV002541877
150 T>A Pontocerebellar hypoplasia type 1B Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000161917
CA273761
rs730882145
191 G>C Pontocerebellar hypoplasia type 1B [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
rs797045567
RCV000625808
CA205371
RCV000192511
191 G>D Pontocerebellar hypoplasia type 1B [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
rs1160669103
RCV002499349
RCV000729415
208 R>N* Pontocerebellar hypoplasia type 1B [ClinVar] Yes ClinVar
dbSNP
rs3208406
VAR_054098
RCV000261175
CA152804
RCV000117007
COSM3763940
225 Y>H Pontocerebellar hypoplasia type 1B large_intestine [ClinVar, Cosmic] Yes ClinGen
cosmic curated
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA5062677
rs140199968
RCV001168094
237 I>L Pontocerebellar hypoplasia type 1B [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA260047
RCV000024370
VAR_068508
rs672601332
238 W>R Pontocerebellar hypoplasia type 1B PCH1B [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
RCV000873613
RCV001697797
CA5062671
rs62640004
253 I>V Pontocerebellar hypoplasia type 1B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs565320740
CA5062668
RCV000692228
261 T>M Pontocerebellar hypoplasia type 1B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
RCV002535481
CA5062666
RCV000818706
rs767942736
262 S>L Pontocerebellar hypoplasia type 1B Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
rs1828567719
RCV001246208
274 E>missing Pontocerebellar hypoplasia type 1B [ClinVar] Yes ClinVar
dbSNP
rs1325914775
RCV001200536
1 M>T No ClinVar
dbSNP
CA373476222
rs754046728
2 A>D No ClinGen
ExAC
TOPMed
gnomAD
rs754046728
CA5062895
2 A>G No ClinGen
ExAC
TOPMed
gnomAD
CA373476223
rs1316402133
2 A>S No ClinGen
TOPMed
gnomAD
CA5062896
rs754046728
2 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA373476216
rs754877763
3 E>D No ClinGen
ExAC
TOPMed
gnomAD
rs565950496
CA5062891
3 E>K No ClinGen
1000Genomes
ExAC
gnomAD
rs751582737
CA192954225
4 P>A No ClinGen
ExAC
TOPMed
gnomAD
CA5062888
rs372128042
4 P>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs372128042
CA5062887
4 P>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5062886
rs372128042
4 P>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs751582737
CA5062889
4 P>S No ClinGen
ExAC
TOPMed
gnomAD
CA5062883
rs549030188
5 A>P No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA5062884
rs549030188
5 A>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs769554336
CA5062881
5 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs771263198
CA5062879
6 S>A No ClinGen
ExAC
gnomAD
rs749691951
CA373476208
6 S>C No ClinGen
ExAC
TOPMed
gnomAD
CA5062878
rs749691951
6 S>F No ClinGen
ExAC
TOPMed
gnomAD
CA5062877
rs777930611
7 V>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
CA373476198
rs1462941939
8 A>G No ClinGen
TOPMed
gnomAD
rs1290396912
CA373476202
8 A>T No ClinGen
TOPMed
gnomAD
rs1244869312
CA373476191
9 A>G No ClinGen
TOPMed
CA373476184
rs1268653989
10 E>D No ClinGen
gnomAD
CA373476189
rs1191492203
10 E>Q No ClinGen
TOPMed
rs1432919701
CA373476182
11 S>T No ClinGen
gnomAD
TCGA novel 11 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA373476173
rs1447275667
12 L>P No ClinGen
TOPMed
rs1056166517
CA192954179
12 L>V No ClinGen
TOPMed
gnomAD
rs750268758
CA5062869
13 A>V No ClinGen
ExAC
gnomAD
CA5062868
rs764928491
14 G>D No ClinGen
ExAC
gnomAD
CA373476157
rs1348603622
15 S>I No ClinGen
TOPMed
CA5062866
rs776409249
16 R>G No ClinGen
ExAC
TOPMed
gnomAD
rs369075932
CA5062865
17 A>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA373476146
rs1365011483
17 A>S No ClinGen
TOPMed
rs369075932
CA373476144
17 A>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA915947453
rs1589061488
18 R>S No ClinGen
Ensembl
CA192954132
rs748428324
19 A>P No ClinGen
TOPMed
gnomAD
CA192954126
rs909422654
20 A>P No ClinGen
TOPMed
CA192954123
rs983715030
21 R>C No ClinGen
TOPMed
gnomAD
TCGA novel 21 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs771457344
CA5062862
21 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs1270605620
CA373476112
24 L>V No ClinGen
gnomAD
CA373476101
rs1179552896
26 Q>E No ClinGen
TOPMed
rs1220738136
CA373476098
26 Q>R No ClinGen
gnomAD
rs1057518124
CA16042791
RCV000414156
27 V>G No ClinGen
ClinVar
Ensembl
dbSNP
rs770262381
CA5062859
27 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA5062858
rs140159471
28 V>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs543643932
CA5062856
30 P>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA192954080
rs941644711
32 E>* No ClinGen
Ensembl
rs1441882835
CA373476056
33 E>D No ClinGen
gnomAD
rs750172761
CA5062853
37 P>L No ClinGen
ExAC
gnomAD
rs1427979807
CA373476031
38 E>* No ClinGen
gnomAD
rs1481141170
CA373476025
39 Q>K No ClinGen
gnomAD
CA192954065
rs372713035
40 E>K No ClinGen
Ensembl
rs1254898809
CA373476009
41 D>N No ClinGen
Ensembl
rs1282495625
CA373476005
41 D>V No ClinGen
TOPMed
rs1468382405
CA373475985
44 G>D No ClinGen
gnomAD
rs757129344
CA5062850
45 P>L No ClinGen
ExAC
gnomAD
CA373475974
rs1325254462
COSM3699693
46 G>E large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA373475976
rs1228791845
46 G>R No ClinGen
TOPMed
rs1262765477
CA373475967
47 G>A No ClinGen
TOPMed
gnomAD
rs1262765477
CA373475966
47 G>V No ClinGen
TOPMed
gnomAD
CA373475965
rs1201798021
48 A>T No ClinGen
gnomAD
CA373475959
rs1327033367
49 V>M No ClinGen
TOPMed
CA5062848
rs564844297
50 E>G No ClinGen
1000Genomes
ExAC
gnomAD
CA192954049
rs114878910
51 R>* No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA5062846
rs766811932
52 P>L No ClinGen
ExAC
gnomAD
rs766811932
CA5062845
52 P>Q No ClinGen
ExAC
gnomAD
CA192954044
rs766811932
52 P>R No ClinGen
ExAC
gnomAD
TCGA novel 52 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1404830651
CA373475926
54 S>R No ClinGen
gnomAD
CA5062843
rs773767698
57 A>G No ClinGen
ExAC
gnomAD
CA373475908
rs1359281369
58 R>G No ClinGen
gnomAD
rs1158260197
CA373475903
58 R>S No ClinGen
gnomAD
CA192954030
rs371853233
59 A>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5062842
rs371853233
59 A>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs762278752
CA5062841
60 C>G No ClinGen
ExAC
CA5062839
rs768949188
62 R>Q No ClinGen
ExAC
gnomAD
CA5062840
rs776681485
62 R>W No ClinGen
ExAC
TOPMed
gnomAD
rs896170471
CA373475874
64 R>C No ClinGen
TOPMed
gnomAD
CA192954013
rs896170471
64 R>G No ClinGen
TOPMed
gnomAD
CA5062838
rs747030782
64 R>H No ClinGen
ExAC
gnomAD
rs1315579598
CA373475868
65 V>A No ClinGen
gnomAD
rs62640002
CA373475871
65 V>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1004124500
CA373475853
67 C>W No ClinGen
TOPMed
gnomAD
CA5062835
rs573816850
68 G>D No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs745785017
CA5062836
68 G>R No ClinGen
ExAC
gnomAD
CA5062837
rs745785017
68 G>S No ClinGen
ExAC
gnomAD
CA5062834
rs756970445
69 P>A No ClinGen
ExAC
TOPMed
gnomAD
rs753698044
CA5062833
69 P>R No ClinGen
ExAC
gnomAD
CA373475848
rs756970445
69 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs755802507
CA5062831
71 L>F No ClinGen
ExAC
TOPMed
gnomAD
rs755802507
CA192953972
71 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs1159210845
CA373475833
72 R>P No ClinGen
gnomAD
CA5062829
rs767003713
72 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA5062828
rs759096213
73 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs759096213
CA373475827
73 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA192953951
rs995146188
75 G>V No ClinGen
gnomAD
rs1185942470
CA373475803
77 R>C No ClinGen
gnomAD
CA373475800
rs1471728821
77 R>L No ClinGen
TOPMed
gnomAD
CA373475801
rs1471728821
77 R>P No ClinGen
TOPMed
gnomAD
rs1344111983
CA373475796
78 L>Q No ClinGen
TOPMed
rs929560365
CA192953916
80 V>D No ClinGen
TOPMed
gnomAD
RCV000490031
CA373475788
rs374550999
80 V>L No ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA373475773
CA192953914
rs923278307
82 K>N No ClinGen
TOPMed
gnomAD
CA5062820
rs772252048
83 C>G No ClinGen
ExAC
TOPMed
gnomAD
rs745981409
CA5062819
84 G>S No ClinGen
ExAC
gnomAD
CA5062817
rs770922813
85 R>L No ClinGen
ExAC
gnomAD
rs748976233
CA5062816
87 R>H No ClinGen
ExAC
gnomAD
CA373475749
rs1404319370
87 R>S No ClinGen
gnomAD
CA5062815
rs777626686
88 H>L No ClinGen
ExAC
gnomAD
CA373475735
rs1369223693
89 K>* No ClinGen
gnomAD
CA5062814
rs537289113
RCV000494128
91 P>T No ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs1425936665
CA373475716
92 G>S No ClinGen
gnomAD
rs754445527
CA5062811
95 S>R No ClinGen
ExAC
gnomAD
CA373475683
rs1211945934
97 G>S No ClinGen
gnomAD
rs765608479
CA5062809
98 G>D No ClinGen
ExAC
gnomAD
CA373475677
rs1250379270
98 G>S No ClinGen
gnomAD
rs757789978
CA5062806
99 V>A No ClinGen
ExAC
gnomAD
rs371885660
CA5062805
100 Y>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA373475649
rs1222374498
102 V>L No ClinGen
gnomAD
CA373475643
rs1343499660
103 D>N No ClinGen
gnomAD
rs764503826
CA5062804
104 S>P No ClinGen
ExAC
gnomAD
rs1387099040
CA373475632
105 Q>K No ClinGen
gnomAD
CA373475612
rs1589061236
107 K>R No ClinGen
Ensembl
rs201178873
CA5062803
108 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA373475571
rs1182643567
112 V>G No ClinGen
gnomAD
rs766461372
CA5062775
112 V>I No ClinGen
ExAC
gnomAD
CA5062776
rs766461372
112 V>L No ClinGen
ExAC
gnomAD
rs1214027410
CA373475558
114 G>E No ClinGen
TOPMed
CA192953466
rs999232158
116 H>R No ClinGen
Ensembl
CA373475545
rs1200963997
116 H>Y No ClinGen
gnomAD
CA373475516
rs1410373685
120 I>R No ClinGen
TOPMed
gnomAD
rs145622193
CA373475514
121 V>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1241989144
CA373475504
122 T>I No ClinGen
gnomAD
CA373475487
rs1160115043
125 S>A No ClinGen
gnomAD
TCGA novel 125 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1354190393
CA373475479
126 G>A No ClinGen
gnomAD
rs1354190393
CA373475478
126 G>V No ClinGen
gnomAD
rs769746459
CA5062772
127 D>N No ClinGen
ExAC
gnomAD
CA192953460
rs903357748
128 I>T No ClinGen
TOPMed
gnomAD
CA373475468
rs1472202256
128 I>V No ClinGen
TOPMed
rs373193552
CA373475456
130 K>E No ClinGen
ESP
ExAC
gnomAD
rs373193552
CA5062770
130 K>Q No ClinGen
ESP
ExAC
gnomAD
CA192953447
rs1044124443
131 V>A No ClinGen
TOPMed
gnomAD
CA192953450
rs751936620
131 V>I No ClinGen
Ensembl
CA373475443
rs141138948
132 D>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5062769
rs768507877
132 D>N No ClinGen
ExAC
TOPMed
gnomAD
rs779619010
CA5062768
134 G>A No ClinGen
ExAC
gnomAD
CA373475425
rs1471646898
135 G>E No ClinGen
TOPMed
gnomAD
rs1346042479
CA373475420
136 S>C No ClinGen
TOPMed
rs1187569437
CA373475404
138 P>S No ClinGen
gnomAD
rs778372165
CA5062766
140 S>C No ClinGen
ExAC
TOPMed
gnomAD
CA5062765
rs778372165
140 S>F No ClinGen
ExAC
TOPMed
gnomAD
CA5062764
rs756702077
141 L>S No ClinGen
ExAC
gnomAD
CA192953425
rs573975449
141 L>V No ClinGen
gnomAD
CA373475374
rs781685540
143 Y>* No ClinGen
ExAC
TOPMed
gnomAD
CA5062763
rs753042657
143 Y>F No ClinGen
ExAC
gnomAD
CA5062760
rs751776878
145 S>T No ClinGen
ExAC
gnomAD
CA373475335
rs1444958317
149 A>G No ClinGen
TOPMed
gnomAD
CA373475334
rs1444958317
149 A>V No ClinGen
TOPMed
gnomAD
rs1403967376
CA373475329
150 T>I No ClinGen
gnomAD
rs1207346119
CA373475293
155 P>L No ClinGen
TOPMed
TCGA novel 155 P>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
RCV000498825
rs1247129345
CA373475255
159 V>A No ClinGen
ClinVar
dbSNP
gnomAD
CA192952640
rs989966117
159 V>F No ClinGen
Ensembl
rs1457432634
CA373475240
161 D>E No ClinGen
gnomAD
CA373475247
rs1589059838
161 D>N No ClinGen
Ensembl
rs1256419561
CA373475237
162 L>F No ClinGen
gnomAD
CA373475222
rs1200553521
164 Y>C No ClinGen
gnomAD
CA373475210
rs1185438064
166 Q>* No ClinGen
gnomAD
CA5062740
rs750712880
166 Q>R No ClinGen
ExAC
gnomAD
rs1243330357
CA373475193
168 V>A No ClinGen
gnomAD
CA373475184
rs1370173911
170 A>P No ClinGen
TOPMed
gnomAD
TCGA novel 170 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5062738
rs141077639
171 N>D No ClinGen
1000Genomes
ExAC
CA373475166
rs1589059813
172 K>N No ClinGen
Ensembl
CA5062737
rs753739586
173 D>E No ClinGen
ExAC
TOPMed
gnomAD
rs1055276932
CA192952622
174 M>I No ClinGen
TOPMed
rs763964643
CA5062736
174 M>T No ClinGen
ExAC
TOPMed
gnomAD
rs1415869854
CA373475156
174 M>V No ClinGen
TOPMed
rs760466382
CA5062735
178 M>I No ClinGen
ExAC
TOPMed
gnomAD
CA373475128
rs1332988248
178 M>V No ClinGen
gnomAD
rs980603915
CA192952612
180 C>Y No ClinGen
Ensembl
rs1416171613
CA373475086
183 S>R No ClinGen
gnomAD
rs1425793444
CA373475083
184 C>G No ClinGen
gnomAD
CA5062733
rs771687142
184 C>W No ClinGen
ExAC
rs149049356
CA5062731
186 R>* No ClinGen
ESP
ExAC
gnomAD
CA5062730
rs149049356
186 R>G No ClinGen
ESP
ExAC
gnomAD
CA5062729
rs748839685
186 R>Q No ClinGen
ExAC
rs777230686
CA5062728
187 A>T No ClinGen
ExAC
gnomAD
CA5062727
rs371980686
188 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs749461063
CA192952584
190 M>V No ClinGen
Ensembl
CA5062726
rs730882145
191 G>S No ClinGen
ExAC
gnomAD
CA192952556
rs940040665
197 G>D No ClinGen
TOPMed
gnomAD
rs377071301
CA192952562
197 G>R No ClinGen
ESP
TOPMed
CA5062719
rs764031129
198 L>V No ClinGen
ExAC
gnomAD
rs752745392
CA5062717
199 L>F No ClinGen
ExAC
TOPMed
gnomAD
CA373474983
rs1359623071
201 K>E No ClinGen
gnomAD
CA373474963
rs1228573588
204 L>V No ClinGen
TOPMed
rs1282917090
CA373474952
205 G>V No ClinGen
TOPMed
CA5062715
rs759452295
208 R>G No ClinGen
ExAC
gnomAD
rs1160669103
CA587827893
208 R>N No ClinGen
TOPMed
gnomAD
rs1366126599
CA373474906
210 L>P No ClinGen
gnomAD
CA5062690
rs766063373
213 P>A No ClinGen
ExAC
TOPMed
gnomAD
CA192952219
rs931855358
215 C>R No ClinGen
Ensembl
TCGA novel 216 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs199651233
CA5062687
217 I>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA5062686
rs761430695
220 E>Q No ClinGen
ExAC
gnomAD
rs1464153985
CA373474821
221 V>A No ClinGen
TOPMed
gnomAD
CA373474807
rs1589058991
223 K>N No ClinGen
Ensembl
CA373474804
rs1184277842
224 L>I No ClinGen
TOPMed
rs546917405
CA5062685
225 Y>C No ClinGen
1000Genomes
ExAC
TOPMed
CA373474792
rs1564013680
226 P>T No ClinGen
Ensembl
CA373474784
rs1488568596
227 L>P No ClinGen
gnomAD
rs955554007
CA192952209
228 E>D No ClinGen
TOPMed
CA5062680
rs530072674
229 I>M No ClinGen
1000Genomes
ExAC
gnomAD
CA373474772
rs1257053779
229 I>T No ClinGen
gnomAD
rs1030215578
CA192952207
229 I>V No ClinGen
TOPMed
rs1360536749
CA373474761
231 F>S No ClinGen
TOPMed
CA5062679
rs374094769
231 F>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1232515479
CA373474731
235 G>E No ClinGen
gnomAD
CA373474733
rs1258608435
235 G>R No ClinGen
gnomAD
CA373474728
rs1330065411
236 R>G No ClinGen
TOPMed
CA192952201
rs370386041
237 I>M No ClinGen
ESP
TOPMed
rs1303049269
CA373474720
237 I>T No ClinGen
gnomAD
CA5062678
rs140199968
237 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs944335096
CA192952198
238 W>C No ClinGen
gnomAD
CA373474709
rs1202043884
239 V>L No ClinGen
TOPMed
gnomAD
CA5062676
rs748282500
242 K>N No ClinGen
ExAC
gnomAD
CA5062674
rs754973221
COSM1187724
247 T>A lung [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA373474647
rs561283125
248 L>* No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs561283125
CA5062673
248 L>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1309761842
CA373474626
251 A>G No ClinGen
gnomAD
CA5062672
rs139360012
251 A>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA5062670
rs750016815
255 E>* No ClinGen
ExAC
TOPMed
gnomAD
rs1178620238
CA373474599
255 E>A No ClinGen
gnomAD
rs1477698046
CA373474586
257 C>Y No ClinGen
TOPMed
rs764975416
CA5062669
260 M>V No ClinGen
ExAC
rs565320740
CA373474554
261 T>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA5062664
rs139911906
263 D>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA373474543
rs1199391491
263 D>E No ClinGen
TOPMed
gnomAD
CA192952182
rs139911906
263 D>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA192952178
rs1023854547
266 K>R No ClinGen
gnomAD
CA5062663
rs771261237
267 Q>K No ClinGen
ExAC
gnomAD
CA373474516
rs1233655344
267 Q>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA5062662
rs763414837
268 I>F No ClinGen
ExAC
gnomAD
CA373474511
rs1331509367
268 I>N No ClinGen
TOPMed
rs1331509367
CA373474509
268 I>S No ClinGen
TOPMed
CA373474513
rs763414837
268 I>V No ClinGen
ExAC
gnomAD
rs765457042 269 F>missing Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA373474495
rs1436438347
270 S>F No ClinGen
TOPMed
rs770068408
CA5062660
270 S>P No ClinGen
ExAC
gnomAD
rs1400638312
CA373474483
272 L>W No ClinGen
gnomAD
rs768917662
CA5062653
273 A>G No ClinGen
ExAC
gnomAD
CA373474480
rs1305148497
273 A>T No ClinGen
gnomAD
rs746924619
CA5062652
276 S>L No ClinGen
ExAC
TOPMed
gnomAD
rs1380136553
CA373474459
276 S>R No ClinGen
gnomAD
TCGA novel 276 S>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA

No associated diseases with Q9NQT5

No regional properties for Q9NQT5

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q9NQT5

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Nucleus, nucleolus
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

10 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytoplasmic exosome (RNase complex) A ribonuclease complex that has 3-prime to 5-prime processive hydrolytic exoribonuclease activity producing 5-prime-phosphomonoesters. Participates in a multitude of cellular RNA processing and degradation events preventing nuclear export and/or translation of aberrant RNAs. Restricted to processing linear and circular single-stranded RNAs (ssRNA) only. RNAs with complex secondary structures may have to be unwound or pre-processed by co-factors prior to entering the complex, esp if the 3-prime end is structured.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
euchromatin A dispersed and relatively uncompacted form of chromatin that is in a transcription-competent conformation.
exosome (RNase complex) A ribonuclease complex that has 3-prime to 5-prime exoribonuclease activity and possibly endoribonuclease activity, producing 5-prime-phosphomonoesters. Participates in a multitude of cellular RNA processing and degradation events preventing nuclear export and/or translation of aberrant RNAs. Restricted to processing linear and circular single-stranded RNAs (ssRNA) only. RNAs with complex secondary structures may have to be unwound or pre-processed by co-factors prior to entering the complex, esp if the 3-prime end is structured.
nuclear exosome (RNase complex) A ribonuclease complex that has 3-prime to 5-prime processive and distributive hydrolytic exoribonuclease activity and endoribonuclease activity, producing 5-prime-phosphomonoesters. Participates in a multitude of cellular RNA processing and degradation events preventing nuclear export and/or translation of aberrant RNAs. Restricted to processing linear and circular single-stranded RNAs (ssRNA) only. RNAs with complex secondary structures may have to be unwound or pre-processed by co-factors prior to entering the complex, esp if the 3-prime end is structured.
nucleolar exosome (RNase complex) A ribonuclease complex that has 3-prime to 5-prime distributive hydrolytic exoribonuclease activity and in some taxa (e.g. yeast) endoribonuclease activity, producing 5-prime-phosphomonoesters. Participates in a multitude of cellular RNA processing and degradation events preventing nuclear export and/or translation of aberrant RNAs. Restricted to processing linear and circular single-stranded RNAs (ssRNA) only. RNAs with complex secondary structures may have to be unwound or pre-processed by co-factors prior to entering the complex, esp if the 3-prime end is structured.
nucleolus A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

2 GO annotations of molecular function

Name Definition
3'-5'-exoribonuclease activity Catalysis of the sequential cleavage of mononucleotides from a free 3' terminus of an RNA molecule.
RNA binding Binding to an RNA molecule or a portion thereof.

14 GO annotations of biological process

Name Definition
CUT catabolic process The chemical reactions and pathways resulting in the breakdown of cryptic unstable transcripts (CUTs).
DNA deamination The removal of an amino group from a nucleotide base in DNA. An example is the deamination of cytosine to produce uracil.
exonucleolytic catabolism of deadenylated mRNA The chemical reactions and pathways resulting in the breakdown of the transcript body of a nuclear-transcribed mRNA that occurs when the ends are not protected by the 3'-poly(A) tail.
exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) Exonucleolytic digestion of a pre-rRNA molecule to generate the mature 3'-end of a 5.8S rRNA molecule derived from an originally tricistronic pre-rRNA transcript that contained the Small Subunit (SSU) rRNA, the 5.8S rRNA, and the Large Subunit (LSU) rRNA in that order from 5' to 3' along the primary transcript.
isotype switching The switching of activated B cells from IgM biosynthesis to biosynthesis of other isotypes of immunoglobulin, accomplished through a recombination process involving an intrachromosomal deletion involving switch regions that reside 5' of each constant region gene segment in the immunoglobulin heavy chain locus.
nuclear polyadenylation-dependent rRNA catabolic process The chemical reactions and pathways occurring in the nucleus and resulting in the breakdown of a ribosomal RNA (rRNA) molecule, including RNA fragments released as part of processing the primary transcript into multiple mature rRNA species, initiated by the enzymatic addition of a sequence of adenylyl residues (polyadenylation) at the 3' end the target rRNA.
nuclear polyadenylation-dependent tRNA catabolic process The chemical reactions and pathways occurring in the nucleus and resulting in the breakdown of an aberrant or incorrectly modified transfer RNA (tRNA) molecule, initiated by the enzymatic addition of a sequence of adenylyl residues (polyadenylation) at the 3' end the target tRNA.
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' The chemical reactions and pathways resulting in the breakdown of the mRNA transcript body that occurs when the 3' end is not protected by a 3'-poly(A) tail; degradation proceeds in the 3' to 5' direction.
polyadenylation-dependent snoRNA 3'-end processing Any process involved in forming the mature 3' end of a snoRNA molecule linked to prior polyadenylation of the 3'-end of the precursor snoRNA.
positive regulation of isotype switching Any process that activates or increases the frequency, rate or extent of isotype switching.
RNA catabolic process The chemical reactions and pathways resulting in the breakdown of RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage.
RNA processing Any process involved in the conversion of one or more primary RNA transcripts into one or more mature RNA molecules.
rRNA processing Any process involved in the conversion of a primary ribosomal RNA (rRNA) transcript into one or more mature rRNA molecules.
U4 snRNA 3'-end processing Any process involved in forming the mature 3' end of a U4 snRNA molecule.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q3T0E1 EXOSC3 Exosome complex component RRP40 Bos taurus (Bovine) PR
Q7TQK4 Exosc3 Exosome complex component RRP40 Mus musculus (Mouse) PR
10 20 30 40 50 60
MAEPASVAAE SLAGSRARAA RTVLGQVVLP GEELLLPEQE DAEGPGGAVE RPLSLNARAC
70 80 90 100 110 120
SRVRVVCGPG LRRCGDRLLV TKCGRLRHKE PGSGSGGGVY WVDSQQKRYV PVKGDHVIGI
130 140 150 160 170 180
VTAKSGDIFK VDVGGSEPAS LSYLSFEGAT KRNRPNVQVG DLIYGQFVVA NKDMEPEMVC
190 200 210 220 230 240
IDSCGRANGM GVIGQDGLLF KVTLGLIRKL LAPDCEIIQE VGKLYPLEIV FGMNGRIWVK
250 260 270
AKTIQQTLIL ANILEACEHM TSDQRKQIFS RLAES